Company
Exciva
We are developing a groundbreaking therapy that effectively and safely addresses neuropsychiatric symptoms including agitation in patients with Alzheimer’s disease dementia.
Also known as EXCIVA GmbH
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Heidelberg, Germany
- Founded
- 2016
- Customers
- Patients, Families and caregivers, Healthcare professionals, Pharmaceutical partners
- Legal name
- EXCIVA GmbH
Claim, correct or request removal
Record updated 28 September 2026
About
Established in 2016 in Heidelberg (Germany), EXCIVA is a privately held biotech company focused on developing clinical stage therapeutics for various indications in neuropsychiatry.
Funding snapshot
- Total raised
- $59MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $59M2026-01-20
Funding rounds
- Series B
- $59M2026-01-20, Company stated
- Series A
- 2021-10-26
Products
- Other
- Deraphan
- Web
- Deraphan
- Web
- EXV-802
Loading relationship preview